For the third consecutive year, the pharmaceutical company was named to the 2017 Great Place to Work® ranking among medium-sized multinational businesses across all industries in the country

Moyra Knight, Andrew Lewis and Karl Uhlendorf named to key roles

Astellas to Retain Certain Promising Antibody-Drug Conjugate R&D Programs of Agensys

Astellas recognized by Great Place to Work® Institute

David Musselman and Lynn Gerber named to key regional sales roles

Initiative part of Astellas’ ongoing commitment to communities, veterans and their families through its Living Smart social responsibility platform

Caroline Walkinshaw and Jacquelyn Bonnell named to key global and regional senior roles

Data Supported Initiation of Currently Enrolling Pivotal Phase 3 ADMIRAL Trial

The challenge is open to nearly anyone with a tangible, unique idea to improve cancer care

Employees also raised nearly $60K at Second Annual “One Astellas Spirit Run”

- Amendment accelerates anticipated PROSPER top-line results by two years -

-Pivotal Monotherapy Phase 2 Trial Initiation Planned for 2017-